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INTRODUCTION
The surgical outcome of vestibular schwannoma (VS) is primari-
ly determined by complete tumor removal and preservation of 
neurologic function. With the advent of the operative microscope 
in 1960 (1), the mortality and morbidity rates in the surgical ex-
cision of VS have declined and, consequently, preservation of the 
facial nerve has become an essential aspect of VS surgery. Al-
though facial nerve outcomes are now excellent in over 90% of 
patients in virtually all published series (2), and anatomical and 
functional preservation of the facial nerve have become routine 
with experienced physicians (3), facial paralysis always remains 
a major concern, and preservation of the facial nerve can still be 
challenging, especially in cases of large VSs.
  It is well-known that the size of the VS is a major predictor of 
facial nerve anatomical and functional preservation (4-6). While 
other factors, including age of the patient, previous treatment, 
intraoperative monitoring of the facial nerve, and surgical ap-
proach, have all been implicated as prognostic factors of facial 
nerve function (7), from our experience, to preserve the nerve 
and its function, correct identification of the course of the facial 
nerve adjacent to the tumor, and overcoming the variable dis-
placement patterns of the facial nerve and surgical techniques, 
including surgical approach, are also important factors in decid-
ing the outcome of facial function.
Objectives. To find the main cause of facial nerve dysfunction in vestibular schwannoma (VS) surgery and review the prog-
nosis of facial function in relation to tumor size, preoperative facial function and surgical approach.
Methods. We reviewed the surgical outcome of 134 patients with VS treated in our department between 1994 and 2008. 
All patients included in the study had postoperative facial paralysis after surgical management of their VS. There were 
14 women and 7 men. The mean age was 48.5 years, with a mean follow-up period of 57 months.
Results. Twenty-one patients (sustained facial palsy, 4; newly developed facial palsy, 17) had facial nerve paralysis after sur-
gery: ten patients in large VS and eleven patients in small VS. In large VS group, 4 patients had facial nerve function of 
HB grade II, 3 patients had HB grade III, and 3 patients had HB grade IV. In small VS group, 9 patients had HB grade 
II and 2 patients had HB grade IV. Middle cranial fossa approach rather than translabyrinthine approach for the pres-
ervation of hearing, led to facial nerve deterioration and the patients who had facial nerve paralysis perioperatively, 
had resulted in permanent facial paralysis.
Conclusion. The tumor size in VS is certainly one of the most important prognostic factors. However, VS tumor size alone 
should not be considered a unique prognostic indicator. The surgical approach used, which may be related to tumor 
size, based on the surgeon’s experience, can be a deciding factor, and the status of the facial nerve injured by the tumor 
can influence postoperative facial nerve function.
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  Whatever size the tumor is, all patients are informed of possi-
ble surgical complications and the unpredictable prognosis of fa-
cial paralysis beyond limited reversibility of good facial nerve 
function, because preservation of facial nerve function is com-
plex, due to extreme stretching and vulnerability, regardless of 
VS size. Further, anatomical nerve integrity does not necessarily 
mean a functional facial nerve.
  In the present study, we tried to find the cause of facial nerve 
dysfunction in VS surgery and review the prognosis of facial 
function in relation to many factors; we also discuss ways to 
protect the facial nerve in patients diagnosed with a large VS.
MATERIALS AND METHODS
Patient population
This study was approved by the institutional review board at the 
investigators’ institution. Data were obtained from our tertiary 
referral center acoustic tumor database originally developed to 
study practice trends from 1994 to 2008. In total, 134 consecu-
tive patients underwent surgical removal of VS. Of them, in 50, 
the VSs were >20 mm in their largest extra-meatal diameter, 
and in 84, the VSs were ≤20 mm.
  A retrospective chart review of the patients was performed. 
Patient documentation, pre- and postoperative neuroradiological 
data, operative reports, and follow-up data were reviewed. The 
following information relevant to the study was recorded: patient 
age, gender, initial signs, tumor size, neurological status at pre-
sentation, surgical complications, and changes in facial function.
Group A (50 patients with large VS, tumor size >20 mm)
The mean age was 47.9 years (range, 14 to 70 years); there were 
15 men (30%) and 35 women (70%). The left side was involved 
in 23 cases and the right in 27. Eleven patients had giant tumors 
(>40 mm), six patients had large tumors (31-40 mm), and 33 
patients had moderately large VS tumors (21-30 mm). Two pa-
tients were treated with staged operations, due to the large size 
of their tumors. Two patients had undergone radiosurgical treat-
ment previously.
Group B (84 patients with small VS, tumor size ≤20 mm)
The mean age was 48.9 years (range, 11 to 73 years); there were 
32 men (38%) and 52 women (62%). The left side was involved 
in 43 cases and the right in 41. Fifteen patients had small tumors 
(1-10 mm) and 69 patients had medium tumors (11-20 mm). 
Evaluation of tumor size
The size of the tumor was determined based on linear planimet-
ric measurements according to international criteria (8), and only 
the largest extra-meatal diameter was used. The portion of tumor 
located inside the internal auditory canal (IAC) was not includ-
ed in the measurement, but tumors located wholly inside the IAC 
were included in small tumors.
Evaluation of facial nerve function and hearing levels
Preoperative and postoperative facial nerve function was as-
sessed according to the House-Brackmann scale (9) and was 
checked by follow-up over 1 year. Pre- and postoperative hear-
ing data were recorded using Academy of Otolaryngology-Head 
and Neck Surgery (AAO-HNS) criteria, including the four-fre-
quency pure tone average (PTA) at 500 Hz, 1 kHz, 2 kHz, and 3 
kHz, and the word recognition score presented at 40 dB hearing 
level (HL) at phonetically balanced maximum. Pre- and postop-
erative hearing was classified according to the guidelines pub-
lished by the Committee on Hearing and Equilibrium of the 
AAO-HNS (10).
Surgical procedure and postoperative care
The surgical approach was selected on the basis of the location 
and size of the tumor and the presence or absence of serviceable 
hearing. Other factors, such as age, anatomy, and contralateral 
hearing levels, were also taken into consideration. If hearing 
preservation was not a goal, a translabyrinthine approach was 
usually used. The middle cranial fossa approach was selected in 
case of laterally-located, small tumors, with serviceable hearing 
levels. However, for the final selection of surgical approach, ser-
viceable hearing was decided by the patient, after careful coun-
seling by a neuro-otologist.
  All the translabyrinthine approach and middle cranial fossa 
approach procedures were performed in an identical fashion. 
Facial nerve monitoring (NIM-Response 2.0 Nerve Integrity 
Monitoring System, Medtronic Xomed Surgical Products Inc., 
Jacksonville, FL, USA) was used to identify and confirm the 
function of the facial nerve intraoperatively.
  The surgical technique for the translabyrinthine approach was 
that described by House, with minor modifications (11, 12). The 
facial nerve identified at the labyrinthine segment, as the un-
changed landmark of location of facial nerve regardless of tumor 
size or tumor shape, widening the exposed window of the later-
al IAC at the transverse crest. The superior and inferior vestibu-
lar and cochlear nerves were separated from facial nerve and 
disarticulated from the lateral canal. Along the exposed traveling 
of the facial nerve, the mass was debulked and removed. At the 
same time, tumor was dissected at the pontomedullary junction 
with medial to lateral direction, continuing the identification of 
the facial nerve. Frequent facial nerve identification and stimula-
tion to monitor the response were performed throughout the 
procedure. Finally, the tumor was debulked and dissected com-
pletely while keeping the direct vision of the facial nerve. Once 
the entire tumor was removed, the dura was approximated with 
sutures, and abdominal fat was packed into the dura opening for 
a watertight closure.
  Middle cranial fossa procedures were performed in selected 
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a Greenberg retractor system was used to provide enhanced ex-
posure. The middle meningeal artery was routinely divided to 
allow placement of the retractor blade over the petrous ridge. To 
avoid the injury of the cochlea and cochlear nerve, widening of 
internal auditory canal was performed around the perigenicu-
late ganglion with little damage of cochlea and identification of 
cochlear nerve at the middle of internal auditory canal was pre-
ferred with sharp dissection from tumor using microscissors or 
microknives (13, 14). From the proximal tympanic portion to 
IAC portion, the facial nerve was exposed and decompressed.
  The tumor was completely removed in all cases except two. 
Computed tomography (CT) with a bony window was performed 
within 1 day of the operation. Completeness of tumor resection, 
facial nerve function, including sign and symptoms, audiograms, 
if needed, and imaging materials were used to evaluate the pa-
tient’s postoperative condition.
Outcome measurement and statistical analyses
Outcome measurements included complete removal of the tu-
mor, facial nerve function, audiograms, imaging materials, includ-
ing postoperative CT scans, magnetic resonance imaging, pho-
tography, and recorded videography, and the surgical complica-
tion rate. The chi-squared and Fisher’s exact tests were used to 
compare outcomes. A difference at a probability level ≤0.05 
was deemed to indicate statistical significance.
RESULTS
Group A
The mean size of the VS was 29.9 mm. The mean time to follow-
up assessment was 14.5±8.6 months (median, 12.1). The most 
frequent neurological deficit at presentation was hearing distur-
bance, observed in all 50 patients; 18 patients (36%) had com-
plete hearing loss. Average pure tone audiometry was 78.3 dB 
on the diseased side (scale-out was considered as a hearing level 
of 120 dB). Tinnitus and vestibular dysfunction were noted in 36 
(72%) and 32 patients (64%), respectively. Five patients had 
preoperative facial nerve paralysis; HB grade II in four patients, 
grade III in one patient. One patient presented with hemifacial 
spasm. Abducent nerve palsy was present in one patient (2%) 
and four patients (8%) had low cranial nerve dysfunction.
  Tumor removal using a translabyrinthine approach was con-
ducted in 48 patients and a middle cranial fossa approach in two 
patients. The VSs were totally removed in 48 of the group A pa-
tients. Incomplete tumor removal led to staged operations in two 
patients with very large tumors extending to the brainstem, and 
facial function was normal after the final operation in these pa-
tients.
  The anatomical integrity of the facial nerve was preserved in 
48 patients (96%). In the other two patients (4%), the nerve 
was found to be extremely flaccid and atrophic, and restoration 
of facial nerve continuity was created with harvested sural nerve. 
Three patients had complete facial paralysis immediately after 
surgery, including those with loss of the anatomical integrity of 
the nerve. Despite the preservation of the nerve in one patient, 
complete facial nerve paralysis continued and hypoglossal-facial 
anastomosis was performed 3 months later. Follow-up examina-
tion showed that facial nerve function recovered to HB grade IV 
in three patients.
  The most common complication was cerebrospinal fluid (CSF) 
leakage, either from the wound or rhinorrhea. Of the 50 proce-
dures, 8 patients (16%) had a CSF leak requiring surgical repair. 
Among them, 7 patients had undergone translabyrinthine ap-
proach and 1 patient had undergone middle cranial fossa ap-
proach. Two patients developed intracranial hemorrhage and 
one patient had postoperative wound infection (Table 1).
Group B
The mean size of the VS was 12.8 mm. The mean time to follow-
up assessment was 13.5±9.3 months (median, 11.8). The most 
frequent neurological deficit at presentation was hearing distur-
bance, observed in 75 patients. Five patients (5.9%) had com-
Table 1. Comparisons of clinical presentation and surgical outcomes 
between two groups
Group A Group B
No. of patients  50 84
Mean age of patients (years) 47.9  48.9
Clinical presentation
Hearing disturbance 50 (100) 73 (87)
Average PTA (dB) 78.3 51.3
Complete hearing loss 18 (35)* 5 (5.9)*
Tinnitus 36 (72) 49 (58)
Vestibular dysfunction 32 (64) 38 (45)
Facial nerve paralysis 5 (10)* 2 (2.4)*
Abducent nerve paralysis 1 (2) 0
Lower cranial nerve dysfunction 4 (8) 0
Mean tumor size (mm) 29.9 12.8
Surgical technique
Translabyrinthine approach 48 (96) 60 (71)
Middle cranial fossa approach 2 (4) 24 (29)
Postoperative facial nerve paralysis 10 (20) 11 (13)
HB grade II  4 (8) 9 (11)
HB grade III  3 (6) 0
HB grade IV at last follow-up 3 (6) 2 (2.3)
Mean HB grade (immediate/final) 1.76/1.48 1.58/1.19
Incomplete tumor removal 2 (4) 0
Postoperative complication 11 (22) 8 (9.5)
CSF leakage requiring repair 8 (16) 6 (7.1)
Intracranial hemorrhage 2 (4) 0
Meningitis 0 2 (2.3)
Wound infection  1 (2) 0
Values are presented as number (%).
PTA: pure tone average; CSF: cerebrospinal fluid.
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plete hearing loss. Average pure tone audiometry was 51.3 dB 
on the diseased side (scale-out was considered as a hearing level 
of 120 dB). Tinnitus and vestibular dysfunction were noted in 49 
(58%) and 38 patients (45%), respectively. Two patients had pre-
operative facial nerve paralysis, HB grade III in both. One patient 
presented with hemifacial spasm. No patient had low cranial 
nerve dysfunction.
  Tumor removal using a translabyrinthine approach was con-
ducted in 60 patients and a middle cranial fossa approach was 
used in 24 patients. The VSs were totally removed in all group B 
patients.
  The most common complication was CSF leakage, either from 
the wound or rhinorrhea. Of 84 procedures, six patients (7.1%) 
had a CSF leak requiring surgical repair. Among them, 2 patients 
had undergone translabyrinthine approach and 4 patients had 
undergone middle cranial fossa approach and two patients (2.3%) 
developed meningitis (Table 1).
Details of patients who had facial nerve paralysis after surgery
Twenty-one patients had facial nerve paralysis after surgery: 10 
in group A and 11 in group B.
Facial paralysis in group A
The mean preoperative HB score was 1.5. Four patients had 
preoperative facial nerve paralysis and six patients had normal 
facial function. All had immediately impaired facial function af-
ter surgery (mean HB score, 3.6), and their final mean HB score 
was 2.9. Immediate and complete facial paralysis indicated a 
poor prognosis for facial function at last follow-up. Four (80%) 
of five patients who had preoperative facial weakness had facial 
paralysis after surgery and one patient had restored facial func-
tion after surgery.
  The average tumor size was 32.6 mm (range, 22 to 60 mm). 
Tumor removal using a translabyrinthine approach was conduct-
ed in eight patients and a middle cranial fossa approach in two. 
In group A, all the patients who had been operated on using a 
middle cranial fossa approach had postoperative facial nerve pa-
ralysis.
  At last follow-up, four patients had facial nerve function of HB 
grade II, three patients had HB grade III, and three patients had 
HB grade IV. No patient had complete facial paralysis (Table 2).
Facial paralysis in group B
The mean preoperative HB score was 1. All had normal facial 
function preoperatively and had immediately impaired facial 
function after surgery (mean HB score, 3.27), and their final 
mean HB score was 2.36. Fifteen patients had immediate facial 
nerve paralysis after surgery and eleven patients (73%) had not 
recovered their facial function completely at the last follow-up.
Average tumor size was 12.7 mm (range, 5 to 18 mm). Tumor 
Table 2. Summary of the patients who had postoperative facial nerve paralysis
Patients Sex/age
Facial nerve function Preop audiom-
etry (PTA/WRS)
Postop audiom-
etry (PTA/WRS)
Tumor size 
Surgical  
approach
Complication
Preop HB Postop HB
Group A F/14 1 2 SO SO 60 Translab CSF leakage
(n=10/50, 20%) F/53 1 2 58/24 SO 22 Translab -
M/48 2 3 15/100 15/100 22 MCF -
M/33 1 4 33/100 SO 25 MCF CSF leakage
M/63 3 4 SO SO 25 Translab -
F/59 1 2 SO SO 40 Translab -
F/48 1 4 SO SO 37 Translab -
F/45 2 2 64/8 SO 33 Translab -
F/62 1 3 118/15 SO 34 Translab -
F/49 2 3 59/5 SO 28 Translab
Average Mean age, 44.4 1.5 2.9 82.7/25.2 109.5/10 32.6 - 2/10 (20%)
Group B F/38 1 2 39/62 SO 10 MCF -
(n=11/84, 13.1%) F/51 1 2 53/78 SO 15 Translab -
M/59 1 2 43/88 49/88 15 MCF -
F/50 1 4 24/98 39/100 5 MCF -
M/43 1 2 18/100 23/100 15 MCF CSF leakage
F/53 1 2 66/0 SO 10 Translab -
F/46 1 2 10/94 20/94 5 MCF Meaningitis
M/58 1 2 66/24 SO 17 Translab -
F/54 1 2 76/28 SO 15 Translab -
M/53 1 2 28/88 54/55 15 MCF CSF leakage
F/70 1 4 76/14 SO 18 Translab -
Average Mean age, 52.3 1 2.36 45.4/61.3 82.3/39.7 12.7 - 3/11 (27%)
PTA: pure tone average; WRS: word recognition score; SO: scale-out; CSF: cerebrospinal fluid; MCF: middle cranial fossa.172    Clinical and Experimental Otorhinolaryngology   Vol. 4, No. 4: 168-173, December 2011
removal using a translabyrinthine approach was conducted in 
five patients and a middle cranial fossa approach in six.
  The anatomical integrity of the facial nerve was preserved in 
all patients. At last follow-up, nine patients had facial nerve func-
tion of HB grade II and two patients had HB grade IV. None of 
the patients had complete facial paralysis (Table 2).
DISCUSSION
The surgical results associated with the resection of large VS have 
steadily improved over the past four decades. The final results 
for patients from whom large tumors were removed are mea-
sured by several factors: morbidity and mortality statistics, com-
pleteness of resection, and postoperative neural function. As 
surgical techniques and individual physician’s experiences have 
improved, the expectation of preservation of facial function has 
increased (15).
  As tumor size increases, however, facial nerve preservation is 
increasingly difficult (16). An important finding of our study is 
that other factors, even if they are related to tumor size, also ex-
ist.
  First, a surgical technique using a middle cranial fossa ap-
proach, in an attempt at hearing preservation in patients with 
levels of serviceable hearing, can lead to facial nerve deteriora-
tion. Although hearing preservation is largely dependent on the 
surgeon’s technique, decision making, and availability of refined 
supermicrosurgical instruments, factors such as experience, skill, 
and determination are very difficult to measure and statistically 
compare between surgeons (17).
  Our data show a 62.5% (15/24 patients) hearing preservation 
rate in all attempted tumors, but of those patients who under-
went hearing preservation surgery for VS, 33% (8/24 patients) 
of them suffered facial nerve dysfunction. That is, the middle 
cranial fossa approach is a more dangerous technique, and it is 
statistically significantly (chi-square test) more common to injure 
the facial nerve than when using a translabyrinthine approach 
(facial nerve paralysis rate, 12%; 13/108 patients). Many authors 
had reported no difference in facial nerve outcomes between VS 
surgical techniques (18, 19). However, in our experience, some 
limitations of the middle fossa approach for complete VS tumor 
removal lead to more common nerve injury, including the limit-
ed posterior fossa approach, the unfavorable position relative to 
the facial nerve, and the limited surgical field due to temporal 
lobe retraction.
  In cases of huge VS, a reliable method is to find the facial nerve 
at the fundus of the internal auditory canal before the mass is 
debulked and removed because it is impossible to find the facial 
nerve at the brainstem and separate it from the tumor capsule, 
which is indented in the brainstem (20).
  Second, perioperative facial dysfunction can lead to persistent 
facial sequelae. Among the patients who had preoperative facial 
dysfunction due to VS (n=7), four patients had facial nerve pa-
ralysis after surgery. Immediate, complete facial paralysis after 
surgery indicates a poor prognosis for facial nerve function. There 
were no patients with delayed facial paralysis, but in a significant 
number of the patients who had facial nerve paralysis immedi-
ately after surgery, the result was permanent facial paralysis 
(72%, 21/29 patients). Of these, eight patients (postoperative 
HB grade II in 5, III in 3 patients) recovered full facial function 3 
6 months after surgery.
  In the comparison between the groups, we found that the tu-
mor size influenced the clinical presentation with regard to fa-
cial function as well as hearing dysfunction, tinnitus, vestibular 
dysfunction, and lower cranial dysfunction. Preoperative com-
plete hearing loss was commonly found in patients with large 
VS (statistically significantly so by Fisher’s exact test). Postopera-
tive complications were also more frequent in large VS than in 
small VS, but not statistically significantly so.
  According to our data, VS tumor size is certainly one of the 
most important prognostic factors. However, tumor size alone 
must not be considered to be a unique prognostic indicator. The 
surgical approach used, which may be related to tumor size, 
based on the surgeon’s experience, can be a deciding prognostic 
factor, including facial nerve function, postoperative complica-
tions, and completeness of tumor removal. Also, the status of 
the facial nerve, injured directly or indirectly by the tumor, can 
influence the destiny of postoperative facial nerve function.
  In conclusion, preservation of facial nerve function in VS sur-
gery is complex, due to extreme stretching and vulnerability, re-
gardless of VS size. The tumor size in VS is certainly one of the 
most important prognostic factors. However, VS tumor size alone 
should not be considered a unique prognostic indicator. The sur-
gical approach used, which may be related to tumor size, based 
on the surgeon’s experience, can be a deciding factor, and the 
status of the facial nerve injured by the tumor can influence post-
operative facial nerve function.
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